Search

Search Constraints

You searched for: Author/Creator Matsumoto, Yasuo

Search Results

1. Achieving PSA < 0.2 ng/ml before Radiation Therapy Is a Strong Predictor of Treatment Success in Patients with High-Risk Locally Advanced Prostate Cancer. (9th October 2019)

2. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma. (17th September 2020)

3. Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database. (6th July 2018)

4. Factors related to primary cancer death and non‐primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases. (6th October 2020)

5. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. (17th March 2021)

6. Multicenter phase I/II study of chemoradiotherapy with high-dose CDDP for head and neck squamous cell carcinoma in Japan. Issue 5 (October 2018)

7. Prognostic Value of Epithelial Cell Adhesion Molecules in T1‐2N0M0 Glottic Cancer. (28th December 2020)

8. Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control. (November 2022)

9. Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity. (26th March 2020)